Bamlanivimab Etesevimab

Angie Szumlinski News

On May 26, 2021, The U.S. Department of Health & Human Services posted an update regarding the use of Bamlanivimab and Etesevimab monoclonal antibody therapy. Distribution for these products have been paused in Illinois, Massachusetts, Arizona, California, Florida, Indiana, Oregon, and Washington until further notice. Please read the full update below for more information.

May 26, 2021 Update- Office of the Assistant Secretary for Preparedness and Response